Evogliptin and metformin combo effective for type 2 diabetes treatment: JAPI Medha Baranwal4 Feb 2021 3:15 PM ISTMumbai, Maharashtra: Combination therapy of Evogliptin and Metformin could be a promising treatment strategy for type 2 diabetes (T2D), finds a recent...
Ipragliflozin Vs Sitagliptin in T2D with Metformin: A glimpse of NISM study MD Bureau2 Feb 2021 9:46 PM ISTAccording to US and European guidelines, sodium - glucose co - transporter - 2 (SGLT2) inhibitors are considered second‐line drugs after metformin for...
Low Dose of Metformin May Prevent Development of AMD: JAMA Study MD Bureau30 Jan 2021 11:15 AM ISTMetformin, classified as biguanide, is the first - line and most widely used medication for patients with type 2 diabetes. In addition to its main...
Long-term use of metformin may reduce breast cancer risk in diabetes patients Dr. Kamal Kant Kohli29 Jan 2021 7:18 AM ISTResearchers have found in a new study that long-term use of metformin may reduce breast cancer risk associated with T2D. In the study metformin use in...
Metformin has cardiorenal safety in diabetics with CKD but may not decrease MACE Dr. Nandita Mohan21 Jan 2021 10:44 AM ISTResearchers have recently found that participants with chronic kidney disease from two cardiovascular outcomes trials support the cardiorenal safety...
NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch Farhat Nasim15 Jan 2021 7:06 PM ISTNew Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...
Metformin significantly lowers COVID-19 related mortality in diabetes patients Dr. Kamal Kant Kohli15 Jan 2021 12:45 PM ISTBIRMINGHAM, Ala. - COVID-19 is a growing pandemic with an increasing death toll that has been linked to various comorbidities as well as racial...
Granules India gets USFDA nod to Metformin Hydrochloride ER tablets for diabetes management Hina Zahid14 Jan 2021 5:45 PM ISTNew Delhi: Drug firm Granules India on Wednesday said it has received the US health regulator's approval for Metformin Hydrochloride extended-release...
Dapagliflozin going off-patent- NPPA brings Dapagliflozin, Metformin Combination under price control Farhat Nasim14 Jan 2021 5:15 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin going off-patent, the apex drug price regulator, National Pharmaceutical Pricing...
NPPA fixes retail price of 7 formulations, Details Ruchika Sharma9 Jan 2021 3:24 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
Metformin does not reduce BPH incidence in men with diabetes: BMJ study Dr Kartikeya Kohli29 Dec 2020 6:39 PM ISTIt has been hypothesised that insulin resistance and increased fasting plasma insulin are promoters of both Benign prostatic hyperplasia (BPH) and...
